RA
Riti Agrawal
About Riti Agrawal
Data last updated:
Riti Agrawal is a Director at Aclima Therapeutics Derive Private Limited (since 2018). The company operates in Pharma. Aclima Therapeutics Derive Private Limited reported revenue of ₹57.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aclima Therapeutics Derive Private Limited U51909UP2017PTC097522 | Director | 29 May 2018 | 2017 | ₹57.2 Lakh (FY 2025) | Active |
Board colleagues of Riti Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Agrawal | 02096227 | Aclima Therapeutics Derive Private Limited | Director |
| Parul Agrawal | 07951841 | Aclima Therapeutics Derive Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Riti Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riti Agrawal
Riti Agrawal currently holds 1 directorship: Aclima Therapeutics Derive Private Limited (Director, since 29 May 2018, revenue ₹57.2 Lakh (FY 2025)).
Riti Agrawal was first appointed on 29 May 2018 as Director at Aclima Therapeutics Derive Private Limited.
The current boards of Riti Agrawal's companies include Ashish Agrawal (Aclima Therapeutics Derive Private Limited), Parul Agrawal (Aclima Therapeutics Derive Private Limited).